eMedicine Specialties > Infectious Diseases > CNS Infections

Western Equine Encephalitis

Author: Mohan Nandalur, MD, Staff Physician, Department of Internal Medicine, Section of Cardiovascular Medicine, Washington Hospital Center
Coauthor(s): Andrew W Urban, MD, Chief, Section of Infectious Diseases, Middleton Memorial Veterans Hospital; Clinical Assistant Professor, Department of Internal Medicine, University of Wisconsin at Madison
Contributor Information and Disclosures

Updated: Oct 31, 2007

Introduction

Background

Encephalitis is defined as an acute inflammation of the brain parenchyma, often with secondary meningeal involvement. Although some bacterial, fungal, and autoimmune disorders are capable of causing encephalitis, most cases are secondary to viruses. The incidence is 1 case per 200,000 population in the United States, with herpes simplex virus being the most prominent cause and arboviruses accounting for 10% (occasionally 50% during epidemic years) of cases.

Western equine encephalitis (WEE) is spread primarily by the vector mosquito Culex tarsalis. Other mosquitoes (eg, Aedes species) and, occasionally, small wild mammals also have been known to spread the virus. C tarsalis is a mosquito that often is found on the west coast of the United States and prefers warm and moist environments. In these locations, cycles of wild bird and mosquito interactions and infectivity allow the virus to remain endemic. No cases of bird transmission of the disease have been reported, making mosquitoes the primary vector and birds simply reservoirs. Epidemic outbreaks in the equine or pheasant population often precede human epidemics of WEE.

WEE is of the genus Alphavirus and in the family Togaviridae. WEE is a summertime infection found in the western United States, and it is more common in rural areas.

WEE is a member of the antigenically similar group of viruses known as Togaviridae, which encompasses eastern equine encephalitis (EEE) and Venezuelan equine encephalitis (VEE). These alphaviruses are spherical and have a diameter of 60-65 nm. The outer layer consists of a glycoprotein shell with protruding glycoprotein spikes, beneath which lies the lipid bilayer. The nucleocapsid core contains the single-stranded RNA genome.

Of the alphaviruses, EEE virus most closely resembles WEE and may have been a genetic predecessor of WEE. The recently completed nucleotide sequence for WEE revealed an 11,508-nucleotide organism with an 84% concordance of protein similarity with EEE.1 Additional cross-genetic research reveals that the virus is an amalgamation of the EEE and Sindbis virus.

Further genetic research has differentiated the potential virulence of particular strains of WEE. Of 3 epizootic strains and 5 enzootic strains, researchers found that the enzootic strains were neither neurovirulent nor neuroinvasive, but the epizootic forms were virulent. Epizootic forms are believed to arise from nonpathogenic strains (eg, AG80-646), which are consistently maintained in enzootic cycles, allowing an opportunity for further screening of vectors with potential precursors of the virulent WEE strains.2

Pathophysiology

The WEE virus is a neurotropic alphavirus, which causes encephalitis and viral symptoms without an associated rash. The disease is usually subclinical and may mimic many viral and inflammatory syndromes.

Diffuse CNS involvement characterizes WEE in its more severe stages. Much of the damage is mediated by the large number of immunologically active cells that enter the brain parenchyma and perivascular areas. Focal necrosis is often found in the striatum, globus pallidus, cerebral cortex, thalamus, pons, and meninges. Neutrophils and macrophages may infiltrate the brain parenchyma and may cause neuronal destruction, neuronophagia, focal necrosis, and spotty demyelination. Vascular inflammation with endothelial proliferation, small vessel thrombosis, and perivascular cuffing may also occur. Cell death by apoptosis occurs primarily in the glial and inflammatory cells. Gross inspection during autopsy reveals edema, leptomeningeal vascular congestion, hemorrhage, and encephalomalacia. In infants or children who die of the disease, diffuse atrophy, particularly of the cortex, may be present.

Pathogen invasion

The virus is transmitted from the mosquito into subcutaneous and cutaneous tissue of the host. It cannot be transmitted via the aerosol route. The virus can also be transferred transplacentally. In the fetus, infection often results in massive cerebral necrosis and death. Infection via contaminated blood transfusions is unlikely because the level of viremia in the donor is extremely low.

The infected individual usually develops a general viral prodrome with fevers, chills, weakness, headache, or myalgias. Viral replication in nonneural tissues, most often adjacent or lymphoid tissue, marks this period.

The virus binds to specific tissue receptors, undergoes endocytosis, and begins an RNA-dependent synthesis of RNA and protein. If the inoculum is high enough, a subsequent viremia develops, with eventual translocation to the CNS via cerebral capillary endothelial cells. The exact mechanism of this is not known but is believed to be secondary to vascular infiltration because factors that increase vascular permeability often facilitate neuroinvasion. Cell-to-cell spread in the CNS occurs via neighboring dendrites and axons.

The initial symptoms may progress rapidly to CNS symptoms of mental confusion, somnolence, coma, and death in 1-2 days, or they may resolve without sequelae.

During epidemics, a significant percentage of the population seroconverts, but the case-infection ratio is low in human adults (1:1000) and high in infants (1:1). Most infected individuals rarely experience severe CNS manifestations, and most infections are subclinical. An inverse ratio has been found between age and clinical CNS manifestations, including seizures and other sequelae.

Frequency

United States

WEE often is found in states west of the Mississippi River, west of the Rocky Mountains, and in the corresponding Canadian provinces. The virus tends to have both a sporadic and a consistent infectivity based on the community. Sporadic cases have occurred in the Sacramento Valley, Calif, but infection is consistent in the nearby Imperial Valley, Calif. Additionally, local strains rarely extend into neighboring environments.

A study of WEE from 4 different regions of northern California revealed that the strains have evolved independently, with little movement between regions. However, in southern California, the virus tends to circulate more freely secondary to the movement of birds and mosquitoes. Most notably, WEE is able to survive a wintering effect and to reappear in a similar region because of an ability to survive in the immature Aedes larva and diapausing eggs. The summer bird– C tarsalis cycle that is then responsible for most infections is secondary to viral amplification during the spring.

WEE is most common between April and September, with peaks in July and August, which likely is due to the peak vector population during these periods.

Although weather plays an important role in the spread of WEE, geographic epidemiology has indicated vector spread via wind distribution is unlikely; thus, epidemic origins are difficult to judge. Warmth is an important factor in the promulgation of the virus because it facilitates an alteration in the transmission rate such that a drop in temperature of a few degrees can differentiate between a 10-month and an 8-month transmission season. Heavy rainfalls or prominently snowy seasons also can increase the vector population.3

The annual incidence of the virus varies greatly because of the presence of both endemic and epidemic forms. The number of cases tends to increase during epidemic years, the worst of which occurred in the western United States and Canadian plains in 1941 and resulted in 300,000 cases of encephalitis in mules and horses and 3336 cases in humans. Because of the geographic and vector similarities between St. Louis encephalitis and WEE, epidemic outbreaks of both frequently overlap.

With the moderate prevalence of WEE in some California communities, neutralizing antibodies originally were believed to be widespread in this population. However, only a low percentage (>1%) of people with these antibodies has been discovered. This finding may be explained by the low rates of contact between infectious mosquitoes and humans.

International

A subtype of WEE found in Argentina has indicated a likely endemic reservoir in South America. Aedes albifasciatus, a neotropical flood mosquito, is the primary vector in this region. The mosquito is relatively ubiquitous and tends to have varied bursts of epidemic growth based on larval concentration factors and weather factors.

Mortality/Morbidity

The case-fatality rates vary for adults and children. The fatality rate is 3-4%, in stark contrast to EEE, which has a 50-70% mortality rate. The morbidity of such illnesses is higher in infants than in adults. Infected children have a 30% chance of developing neurologic sequelae, including retardation, seizures, spasticity, or behavioral disorders. The infectivity rate is 1:1000 in adults, 1:58 in children aged 1-4 years, and 1:1 in infants younger than 1 year.

Race

No racial predilection for WEE exists.

Sex

Based on cumulative cases, WEE is more common in males than in females, which is believed to be secondary to frequent occupational exposure of rural land workers.

Age

WEE is most common among infants because of the high case infection ratio (1:1). Adults are often targets of the vector, but they have a very low infectivity rate (1:1000). However, older adults tend to develop more severe disease. Infants and children younger than 4 years also develop more severe disease and are more likely to develop CNS manifestations of infection with the virus.

Clinical

History

Western equine encephalitis (WEE) is difficult to diagnose because of the lack of specificity in symptoms. Often, the goal in these situations is to determine the extent of the patient's illness and whether treatable CNS infection is a possibility. Most patients commonly present with the initial signs and symptoms of a viral prodrome. The prodromal phase is often short, averaging 1-4 days, and consists of fever, headache, chills, nausea, and vomiting. In many patients, especially adults, the disease may be subclinical, and these patients may never develop symptoms beyond that of the viral prodrome. Physicians must have a heightened awareness for neurologic symptoms and sequelae, especially in younger patients.

  • Neurologic symptoms: Once these symptoms arise, patients have a poorer prognosis and decompensate rapidly.
    • Headache - Often the most prevalent symptom
    • Nausea or vomiting - Present in both the prodromal and the active stages of illness
    • Confusion
    • Focal neurologic deficits (ie, sensory or motor loss in 1 distribution) - Low prevalence
    • Seizures (most commonly of the general tonic-clonic or partial complex) - Greater frequency in very young children
    • Somnolence
    • Neck stiffness
    • Malaise and weakness
    • Cranial nerve palsies (rare)
    • Photophobia
  • Other associated symptoms
    • Vertigo (common)
    • Abrupt fever - Almost invariably present at some point
    • Chills
    • Abdominal pain
    • Diarrhea
    • Sore throat (common)
    • Arthralgias or myalgias
    • Respiratory difficulty (common)
  • Social history
    • Recent travel to endemic areas
    • Outdoor exposure history
    • Work related to the care of horses
    • Recent insect bites
    • Recent illnesses
    • Recent ill contacts
    • Locations of home and work

Physical

The findings on physical examination also are nonspecific and are similar to findings of many other encephalitides.

  • Changes in vital signs
    • Fever
    • Tachycardia
    • Possibly tachypneic
  • Neurologic findings
    • Bilateral papilledema
    • Nuchal rigidity
    • Focal sensory or motor deficit
    • Depressed or hyperactive reflexes
    • Tremors
    • Fasciculations
    • Seizure activity
    • Spastic paralysis
  • Other findings
    • Cyanosis, if respiratory compromise is present
    • Facial, periorbital, or generalized edema
    • Lymphadenopathy (not necessarily present)
    • Possible pharyngeal erythema
    • Infants - Bulging fontanelles (possibly)

Causes

Although no individual risk factors exist except for age, behavioral risk factors exist. Behavioral risk factors primarily include outdoor activities during peak mosquito activity, most often in rural areas.

More on Western Equine Encephalitis

Overview: Western Equine Encephalitis
Differential Diagnoses & Workup: Western Equine Encephalitis
Treatment & Medication: Western Equine Encephalitis
Follow-up: Western Equine Encephalitis
References

References

  1. Netolitzky DJ, Schmaltz FL, Parker MD. Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes. J Gen Virol. Jan 2000;81 Pt 1:151-9. [Medline].

  2. Bianchi TI, Aviles G, Monath TP. Western equine encephalomyelitis: virulence markers and their epidemiologic significance. Am J Trop Med Hyg. Sep 1993;49(3):322-8. [Medline].

  3. Sellers RF, Maarouf AR. Weather factors in the prediction of western equine encephalitis epidemics in Manitoba. Epidemiol Infect. Oct 1993;111(2):373-90. [Medline].

  4. Johnson AJ, Martin DA, Karabatsos N. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol. May 2000;38(5):1827-31. [Medline].

  5. Chiles RE, Reisen WK. A new enzyme immunoassay to detect antibodies to arboviruses in the blood of wild birds. J Vector Ecol. Dec 1998;23(2):123-35. [Medline].

  6. Gahlinger PM, Reeves WC, Milby MM. Air conditioning and television as protective factors in arboviral encephalitis risk. Am J Trop Med Hyg. May 1986;35(3):601-10. [Medline].

  7. Elgart ML. Medical pearl: permethrin can prevent arthropod bites and stings. J Am Acad Dermatol. Aug 2004;51(2):289. [Medline].

  8. Adams RD, Victor M, Ropper AH. Encephalitis. In: Principles of Neurology. 6th ed. New York, NY: McGraw-Hill; 1997:749-55.

  9. Bennet JC, Plum F. Other arthropod-borne infections. In: Cecil Textbook of Medicine. 20th ed. Philadelphia, Pa: WB Saunders; 1996:1810-14.

  10. CDC. Arboviral disease--United States, 1994. MMWR Morb Mortal Wkly Rep. Sep 8 1995;44(35):641-4. [Medline].

  11. Davis NL, Brown KW, Johnston RE. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol. Jun 1996;70(6):3781-7. [Medline].

  12. Deresiewicz RL, Thaler SJ, Hsu L. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med. Jun 26 1997;336(26):1867-74. [Medline].

  13. Francki RIB, Faquet CM, Knudson DI. Classification and nomenclature of viruses. Arch Virol. 1991;2:223.

  14. Fulhorst CF, Hardy JL, Eldridge BF. Natural vertical transmission of western equine encephalomyelitis virus in mosquitoes. Science. Feb 4 1994;263(5147):676-8. [Medline].

  15. Gleiser RM, Urrutia J, Gorla DE. Effects of crowding on populations of Aedes albifasciatus larvae under laboratory conditions. Entomologia Experimentalis et Aplicata. May 2000;95(2):135-140.

  16. Gorbach SL, Bartlett JG, Blacklow NR. Other arthropod-borne viruses. In: Infectious Diseases. Vol 2. Philadelphia, Pa: WB Saunders; 1998:1411-14.

  17. Gutierrez KM, Prober CG. Encephalitis. Identifying the specific cause is key to effective management. Postgrad Med. Mar 1998;103(3):123-5, 129-30, 140-3. [Medline].

  18. Hahn CS, Lustig S, Strauss EG. Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci U S A. Aug 1988;85(16):5997-6001. [Medline].

  19. Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system. N Engl J Med. Feb 11 1999;340(6):483-4. [Medline].

  20. Johnson RT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis. Mar 1987;155(3):359-64. [Medline].

  21. Kramer LD, Fallah HM. Genetic variation among isolates of western equine encephalomyelitis virus from California. Am J Trop Med Hyg. Apr 1999;60(4):708-13. [Medline].

  22. Long MC, Nagata LP, Ludwig GV. Construction and characterization of monoclonal antibodies against western equine encephalitis virus. Hybridoma. Apr 2000;19(2):121-7. [Medline].

  23. Mandell GL. Alphaviruses causing encephalitis. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill-Livingstone; 2000.

  24. Nasci RS, Gottfried KL, Burkhalter KL, et al. Sensitivity of the VecTest antigen assay for eastern equine encephalitis and western equine encephalitis viruses. J Am Mosq Control Assoc. Dec 2003;19(4):440-4. [Medline].

  25. Obrecht RE, Patrick PD. Neuropsychological sequelae of adolescent infectious diseases. Adolesc Med. Oct 2002;13(3):663-81. [Medline].

  26. Reisen WK, Chiles RE. Prevalence of antibodies to western equine encephalomyelitis and St. Louis encephalitis viruses in residents of California exposed to sporadic and consistent enzootic transmission. Am J Trop Med Hyg. Nov 1997;57(5):526-9. [Medline].

  27. Reisen WK, Meyer RP, Presser SB. Effect of temperature on the transmission of western equine encephalomyelitis and St. Louis encephalitis viruses by Culex tarsalis (Diptera: Culicidae). J Med Entomol. Jan 1993;30(1):151-60. [Medline].

  28. Roos KL. Encephalitis. Neurol Clin. Nov 1999;17(4):813-33. [Medline].

  29. Sokolova TM, Selivanova TK, Lebedev AIu. Sindbis viruses of various geographic origin and differentiation of them from Western equine encephalomyelitis viruses using the polymerase chain reaction. Vopr Virusol. May-Jun 1996;41(3):117-22. [Medline].

  30. Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am. Mar 1991;5(1):73-102. [Medline].

  31. Weaver SC, Kang W, Shirako Y. Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses. J Virol. Jan 1997;71(1):613-23. [Medline].

  32. Weaver SC, Lorenz LH, Scott TW. Pathologic changes in the midgut of Culex tarsalis following infection with Western equine encephalomyelitis virus. Am J Trop Med Hyg. Nov 1992;47(5):691-701. [Medline].

Further Reading

Keywords

western equine encephalitis, WEE, inflammation of the brain parenchyma, meninges, herpes simplex virus, arbovirus, Culex tarsalis, C tarsalis, Aedes species, eastern equine encephalitis, EEE, Venezuelan equine encephalitis, VEE, Sindbis virus, neurotropic alphavirus, diffuse CNS involvement, meningitis, meningoencephalitis, St. Louis encephalitis, Aedes albifasciatus, A albifasciatus, encephalitides

Contributor Information and Disclosures

Author

Mohan Nandalur, MD, Staff Physician, Department of Internal Medicine, Section of Cardiovascular Medicine, Washington Hospital Center
Mohan Nandalur, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians-American Society of Internal Medicine, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Coauthor(s)

Andrew W Urban, MD, Chief, Section of Infectious Diseases, Middleton Memorial Veterans Hospital; Clinical Assistant Professor, Department of Internal Medicine, University of Wisconsin at Madison
Andrew W Urban, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine
Disclosure: Nothing to disclose.

Medical Editor

Kenneth C Earhart, MD, FACP, Deputy Head, Disease Surveillance Program, United States Naval Medical Research Unit #3
Kenneth C Earhart, MD, FACP is a member of the following medical societies: American College of Physicians, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Undersea and Hyperbaric Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

John L Brusch, MD, FACP, Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance
John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.